Amneal to Report Third Quarter 2019 Results on November 6, 2019
October 09 2019 - 8:30AM
Business Wire
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) will release
its third quarter 2019 financial results on Wednesday, November 6,
2019, prior to the open of the U.S. financial markets. The Company
will host a conference call and live webcast with the investment
community at 8:30 a.m., Eastern Time on November 6, 2019.
The financial results and live webcast will be accessible
through the Investor Relations section of the Company's Web site at
https://investors.amneal.com. The webcast can also be accessed at
the following URL:
https://event.on24.com/wcc/r/2080000/0FFBE4DA8E819349A7FE463FEA182A89.
To access the call through a conference line, dial (844)
746-0741 (in the U.S.) and (412) 317-5273 (international
callers).
A replay of the conference call will be available for seven days
shortly after the call. To access the replay, dial (877) 344-7529
(in the U.S.) and (412) 317-0088 (international callers). The
access code for the replay is 10135886.
About Amneal
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in
Bridgewater, NJ, is an integrated pharmaceutical company focused on
developing, manufacturing and distributing generic, brand and
biosimilar products. The Company has operations in North America,
Asia, and Europe, working together to bring high-quality medicines
to patients primarily within the United States.
Amneal has an extensive portfolio of more than 300 generic
medicines and is expanding its portfolio to include complex dosage
forms in a broad range of therapeutic areas. The Company also
markets a portfolio of branded pharmaceutical products through its
Specialty segment focused principally on central nervous system
disorders and parasitic infections. For more information, visit
www.amneal.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191009005362/en/
Mark Donohue (908) 409-6718 www.amneal.com
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From Apr 2023 to Apr 2024